摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Benzothiazine derivative 1

中文名称
——
中文别名
——
英文名称
Benzothiazine derivative 1
英文别名
(2Z)-6-[(2,6-dichlorophenyl)methylsulfonyl]-2-[(4-hydroxy-3-nitrophenyl)methylidene]-4H-1,4-benzothiazin-3-one
Benzothiazine derivative 1化学式
CAS
——
化学式
C22H14Cl2N2O6S2
mdl
——
分子量
537.4
InChiKey
DOMBZVXKSRQDOJ-NKVSQWTQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    34
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    163
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • SUBSTITUTED 2-BENZYLIDENE-2H-BENZO[b][1,4]THIAZIN-3(4H)-ONES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF
    申请人:Reddy E. Premkumar
    公开号:US20140086941A1
    公开(公告)日:2014-03-27
    The present invention relates to compounds according to Formula I: and salts thereof, wherein R 1 , R 2 , R 3 , R 4 , Ar, and n are as defined herein. Methods for preparing compounds of Formula I are also provided. The present invention further includes methods of treating cellular proliferative disorders, such as cancer, with the compounds of Formula I.
    本发明涉及公式I的化合物及其盐,其中R1、R2、R3、R4、Ar和n的定义如本文所述。还提供了制备公式I化合物的方法。本发明还包括使用公式I化合物治疗细胞增殖性疾病,如癌症的方法。
  • METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
    申请人:Design Therapeutics, Inc.
    公开号:US20210238226A1
    公开(公告)日:2021-08-05
    The present disclosure relates to compounds and methods for modulating the expression of dmpk, atxn1, atxn2, atxn3, cacna1a, atxn7, ppp2r2br tbp, htt, jph3r ar, or atn1 and treating diseases and conditions in which dmpk, atxn1, atxn2, atxn3, cacna1a, atxn1, ppp2r2b, tbp, htt, jph3, ar, or atn1 plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.
  • US9242945B2
    申请人:——
    公开号:US9242945B2
    公开(公告)日:2016-01-26
查看更多